BINEX Co., Ltd. (KOSDAQ:053030)
11,130
+180 (1.64%)
Apr 10, 2026, 3:30 PM KST
BINEX Market Cap
BINEX has a market cap or net worth of 348.73 billion as of April 10, 2026. Its market cap has decreased by -33.96% in one year.
Market Cap
348.73B
Enterprise Value
426.40B
Revenue
168.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
11,130.00
Market Cap Chart
Since March 1, 2002, BINEX's market cap has increased from 25.29B to 348.73B, an increase of 1,279.15%. That is a compound annual growth rate of 11.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 354.46B | -25.70% |
| Dec 30, 2025 | 477.08B | -18.32% |
| Dec 30, 2024 | 584.09B | 111.03% |
| Dec 28, 2023 | 276.77B | -22.51% |
| Dec 29, 2022 | 357.18B | -24.01% |
| Dec 30, 2021 | 470.05B | -43.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Proteina | 604.95B |
| SillaJen | 517.99B |
| Genomictree | 406.71B |
| Helixmith | 404.29B |
| Anterogen.Co.,Ltd. | 379.23B |
| GC Cell | 347.13B |
| HLB Therapeutics | 275.49B |
| JETEMA, | 265.67B |